SEC Form D · filed February 18, 2021
ELIXIRGEN THERAPEUTICS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (17)
Minoru S. Ko · Baltimore, MDDirectorHiroaki C. Kobayashi · Baltimore, MDDirectorThomas K. White · Baltimore, MDDirectorAkihiro C. Ko · Baltimore, MDExec · DirectorShauna K. Callahan · Baltimore, MDDirectorNaonori Kurokawa · Baltimore, MDDirectorOla Soderquist · Needham, MAExec · DirectorTyson Hunt · Columbia, MODirectorJudson Ball · Columbia, MODirectorAndrew Sharp · Columbia, MODirectorEdward Raha · Ponte Vedra Beach, FLDirectorNatalia Pintus · Cleveland, OHExec · DirectorRiley Chaney · Fresno, CADirectorHelena Foulkes · NEW YORK, NYDirectorJack Sarno · NEW YORK, NYDirectorDamien Hooper-Campbell · NEW YORK, NYDirectorNaonori Kurokawa · Baltimore, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗